We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
Scientific Insights Help Ensure High-Quality Outcomes
At West, our goal is to partner with customers to mitigate risks of drug/packaging incompatibility, container/device and functional challenges. Although we consider critical quality attributes during development of drug packaging and delivery systems, there can be knowledge gaps of various interfaces based on the specific application of use, such as component-to-container, container-to-device, and container-to-drug.
Formed in 2016, Scientific Insights Lab brings together experts with broad knowledge and experience in polymer materials, surface science, biologic drugs and computational modeling. We help customers understand, select, optimize and improve container closure system targeting specific to their drug product applications and manufacturing process.
Our comprehensive protein testing capabilities include:
system screening
protein adsorption analysis
biologic activities assay
primary structure analysis
protein particles & aggregation testing
protein thermal stability
product-related structure & impurities
We also perform surface analytical and functionality testing capabilities to assess drug impacts on containers over time. Using theoretical prediction and experimental verification, we assist our customers to predict long term container/drug compatibility at the early stage of combination product development.
Finally, we can perform container closure system (CCS) compatibility and optimization testing for high-quality performance. When used in combination with the comprehensive container closure integrity (CCI) testing methods, our experts can serve customers with
CCS analysis
components selection/recommendation
process set up, troubleshooting & optimization.
By partnering together, West’s experts offer customers the ability to understand the interactions of containers and their new drug products, to provide solutions of container closure systems to mitigate risks down the road in a close, collaborative customer relationship.
Learn more by watching our video above or visiting our featured video channel for additional videos!
Need immediate shipping of stoppers or seals? West has an efficient niche operation for small quantity fulfillment: our facility in Lititz, Pennsylvania. For those seeking samples, small quantity fulfillment for research and development needs or just a few components, Lititz offers off the shelf, convenient, fast and friendly customer service.
In the pharmaceutical industry, safety and quality are paramount. One critical aspect of ensuring the safety of pharmaceutical products is extractables and leachables (E&L) testing. This testing process examines the potential migration of substances from containers, packaging materials, and drug delivery systems into the drug products themselves. By understanding the reasoning behind E&L testing, we can appreciate its role in protecting public health and enhancing customer trust. West Pharmaceutical Services, Inc. is a leader in developing comprehensive studies to evaluate container closure systems in real world simulations, providing customers with a better understanding of their leachable profile and how that could affect drug stability.
In our last update, we mentioned that we were using real-time data and analytics to guide content growth. Every six months we analyze which of our Knowledge Center categories are the most popular. If a category is heavily accessed, our experts in those areas work to deliver even more cutting-edge information for customers.
West is proud to announce that its 2017 Corporate Responsibility Report has been published and is now live on the West website. In its second year, this report provides a summary of West’s efforts in six key areas including Compliance and Ethics, Philanthropy, Diversity, Health and Safety, Environmental Sustainability and Quality. Being a good corporate citizen is part of West’s DNA. This is evident in our rich history of caring for the communities and environments in which we work and live. The 2017 Corporate Responsibility Report is a testament to this commitment, and we are seeing great progress across all of our focus areas.
My name is Michele Polinsky and I am a breast cancer survivor.<br />These days it’s the simple things that make me happy. Watching my daughter play soccer at Virginia Tech, taking my son to high school and watching his soccer games. Celebrating holidays and birthdays. Simple things that you take for granted when you are healthy. And you start to worry won’t be in your future when you are first diagnosed with cancer. It’s a scary time.
Michele Polinsky
VP Global Communications and Corporate Philanthropy